Prognostic Analysis of Completely Resected Lung Adenocarcinoma with Uncommon EGFR Mutations: CReGYT-01 EGFR Study

被引：0

作者：

Hayasaka, K. ^{[1
,2
]}

Haratake, N. ^{[3
]}

Notsuda, H. ^{[2
]}

Katsumata, S. ^{[1
]}

Hamada, A. ^{[4
]}

Nomura, K. ^{[5
]}

Fujino, K. ^{[6
]}

Yoshikawa, M. ^{[7
]}

Suzawa, K. ^{[7
]}

Shien, K. ^{[7
]}

Suda, K. ^{[4
]}

Ohara, S. ^{[4
]}

Fukuda, S. ^{[4
]}

Kinoshita, I. ^{[3
]}

Takamori, S. ^{[3
,8
]}

Muto, S. ^{[9
]}

Takanashi, Y. ^{[10
]}

Mizuno, K. ^{[10
]}

Kawase, A. ^{[10
]}

Hayakawa, T. ^{[10
]}

Sekihara, K.

Toda, M. ^{[11
]}

Matsuo, S. ^{[12
]}

Takegahara, K. ^{[13
]}

Hashimoto, M. ^{[13
]}

Nakahashi, K. ^{[14
]}

Endo, M. ^{[14
]}

Ozawa, H. ^{[15
]}

Fujikawa, R. ^{[15
]}

Tomioka, Y. ^{[16
]}

Namba, K. ^{[16
]}

Matsubara, T. ^{[17
]}

Suzuki, J. ^{[18
]}

Watanabe, H. ^{[18
]}

Takada, K. ^{[19
]}

Hoshino, H. ^{[20
]}

Toyoda, T. ^{[21
]}

Koki, Y. ^{[22
]}

Shiono, S. ^{[18
]}

Shimokawa, M. ^{[22
]}

Soh, J. ^{[23
]}

Ohde, Y. ^{[1
]}

Okada, Y. ^{[2
]}

机构：

[1] Shizuoka Canc Ctr, Shizuoka, Japan

[2] Tohoku Univ Hosp, Sendai, Miyagi, Japan

[3] Kyushu Univ, Fukuoka, Japan

[4] Kindai Univ, Fac Med, Osaka, Japan

[5] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[6] Kumamoto Univ, Kumamoto, Japan

[7] Okayama Univ Hosp, Okayama, Japan

[8] Oita Univ, Fac Med, Oita, Japan

[9] Fukushima Med Univ, Sch Med, Fukushima, Japan

[10] Hamamatsu Univ, Sch Med, Shizuoka, Japan

[11] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan

[12] Nihonkai Gen Hosp, Sakata, Yamagata, Japan

[13] Hyogo Coll Med, Nishinomiya, Hyogo, Japan

[14] Yamagata Prefectural Cent Hosp, Yamagata, Japan

[15] Shimada Gen Med Ctr, Shizuoka, Japan

[16] Shimane Univ, Matsue, Shimane, Japan

[17] Kitakyushu Municipal Med Ctr, Fukuoka, Japan

[18] Yamagata Univ, Yamagata, Japan

[19] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan

[20] NHO Okinawa Hosp, Okinawa, Japan

[21] Chiba Univ, Grad Sch Med, Chiba, Japan

[22] Yamaguchi Univ, Yamaguchi, Japan

[23] Osaka Metropolitan Univ, Grad Sch Med, Osaka, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

uncommon EGFR mutation; surgery; prognosis;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.07A.03

引用

页码：S232 / S233

页数：2

共 50 条

[1] Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma
Hayasaka, K.
Shiono, S.
Matsumura, Y.
Suzuki, H.
Yanagawa, N.
Abe, J.
Sagawa, M.
Sakurada, A.
Katahira, M.
Takahashi, S.
Endoh, M.
Okada, Y.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1004 - S1004
[2] Clinical Relevance of PD-L1 Expression Levels in Surgically Resected EGFR-Mutant Lung Adenocarcinoma Patients (CReGYT-01 Study)
Kinoshita, F.
Nomura, K.
Takada, K.
Muto, S.
Matsubara, T.
Kouki, Y.
Katsumata, S.
Hamada, A.
Haratake, N.
Fujino, K.
Yoshikawa, M.
Suzawa, K.
Shien, K.
Suda, K.
Ohara, S.
Fukuda, S.
Suzuki, H.
Okamoto, T.
Hirai, F.
Aokage, K.
Shiono, S.
Soh, J.
Tsuboi, M.
Shimokawa, M.
Ohde, Y.
Takenaka, T.
Yoshizumi, T.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S233 - S233
[3] Clinicopathologic and Prognostic Features of Early Resected Lung Adenocarcinoma Characterized with Uncommon EGFR Mutation
Li, S.
She, Y.
Hou, L.
Zhao, D.
Chen, C.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S201 - S201
[4] Prognostic Effect of EGFR Gene Mutation for Recurrence in Completely Resected Lung Adenocarcinoma
Park, I. K.
Hyun, K.
Park, S.
Kang, C. H.
Kim, Y.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2348 - S2348
[5] Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
Marks, Jenifer L.
Broderick, Stephen
Zhou, Qin
Chitale, Dhananjay
Li, Allan R.
Zakowski, Maureen F.
Kris, Mark G.
Rusch, Valerie W.
Azzoli, Christopher G.
Seshan, Venkatraman E.
Ladanyi, Marc
Pao, William
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 111 - 116
[6] Pattern of Recurrence of Completely Resected Lung Adenocarcinoma Varies According to EGFR Mutation Status
Watanabe, K.
Sakamaki, K.
Ito, H.
Yokose, T.
Yamada, K.
Nakayama, H.
Masuda, M.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1007 - S1007
[7] Prognostic and Predictive Implications of EGFR Mutations, EGFR Copy Number and KRAS Mutations in Advanced Stage Lung Adenocarcinoma
Bonanno, Laura
Schiavon, Marco
Nardo, Giorgia
Bertorelle, Roberta
Bonaldi, Laura
Galligioni, Alessandra
Indraccolo, Stefano
Pasello, Giulia
Rea, Federico
Favaretto, Adolfo
ANTICANCER RESEARCH, 2010, 30 (12) : 5121 - 5128
[8] Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors
Brindel, Aurelien
Althakfi, Wajd
Barritault, Marc
Watkin, Emmanuel
Maury, Jean-Michel
Bringuier, Pierre-Paul
Girard, Nicolas
Brevet, Marie
JOURNAL OF THORACIC DISEASE, 2020, 12 (09) : 4643 - +
[9] Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma
Wang, Zeng
Yang, Shifeng
Lu, Hongyang
ONCOTARGETS AND THERAPY, 2017, 10 : 3345 - 3351
[10] Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma
Takamochi, Kazuya
Oh, Shiaki
Matsunaga, Takeshi
Suzuki, Kenji
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (05) : 1768 - +

← 1 2 3 4 5 →